Anti-NRX1B/ NRX1A/ NRXN1 monoclonal antibody

Anti-NRX1B/ NRX1A/ NRXN1 antibody for FACS & in-vivo assay

Target products collectionGo to NRXN1/NRXN1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0908-Ab-1/ GM-Tg-hg-MP0908-Ab-2Anti-Human NRXN1 monoclonal antibodyHuman
GM-Tg-rg-MP0908-Ab-1/ GM-Tg-rg-MP0908-Ab-2Anti-Rat NRXN1 monoclonal antibodyRat
GM-Tg-mg-MP0908-Ab-1/ GM-Tg-mg-MP0908-Ab-2Anti-Mouse NRXN1 monoclonal antibodyMouse
GM-Tg-cynog-MP0908-Ab-1/ GM-Tg-cynog-MP0908-Ab-2Anti-Cynomolgus/ Rhesus macaque NRXN1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0908-Ab-1/ GM-Tg-felg-MP0908-Ab-2Anti-Feline NRXN1 monoclonal antibodyFeline
GM-Tg-cang-MP0908-Ab-1/ GM-Tg-cang-MP0908-Ab-2Anti-Canine NRXN1 monoclonal antibodyCanine
GM-Tg-bovg-MP0908-Ab-1/ GM-Tg-bovg-MP0908-Ab-2Anti-Bovine NRXN1 monoclonal antibodyBovine
GM-Tg-equg-MP0908-Ab-1/ GM-Tg-equg-MP0908-Ab-2Anti-Equine NRXN1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0908-Ab-1/ GM-Tg-hg-MP0908-Ab-2; GM-Tg-rg-MP0908-Ab-1/ GM-Tg-rg-MP0908-Ab-2;
GM-Tg-mg-MP0908-Ab-1/ GM-Tg-mg-MP0908-Ab-2; GM-Tg-cynog-MP0908-Ab-1/ GM-Tg-cynog-MP0908-Ab-2;
GM-Tg-felg-MP0908-Ab-1/ GM-Tg-felg-MP0908-Ab-2; GM-Tg-cang-MP0908-Ab-1/ GM-Tg-cang-MP0908-Ab-2;
GM-Tg-bovg-MP0908-Ab-1/ GM-Tg-bovg-MP0908-Ab-2; GM-Tg-equg-MP0908-Ab-1/ GM-Tg-equg-MP0908-Ab-2
Products NameAnti-NRXN1 monoclonal antibody
Formatmab
Target NameNRXN1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NRXN1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NRX1B/ NRX1A/ NRXN1 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0908
    Target NameNRXN1
    Gene ID9378,18189,60391,619185,474589,101084531,281950,100052908
    Gene Symbol and Synonyms1700062G21Rik,9330127H16Rik,A230068P09Rik,Hs.22998,mKIAA0578,NRXN1,Nrxn1b,PTHSL2,SCZD17
    Uniprot AccessionP58400, Q9ULB1,Q63372,Q63373,Q28142,Q28146
    Uniprot Entry NameNRX1A_HUMAN,NRX1A_RAT,NRX1B_RAT,NRX1B_BOVIN,NRX1A_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000179915
    Target ClassificationN/A

    The target: NRXN1, gene name: NRXN1, also named as Hs.22998, PTHSL2, SCZD17. This gene encodes a single-pass type I membrane protein that belongs to the neurexin family. Neurexins are cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. This complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts. Three members of this gene family have been studied in detail and are estimated to generate over 3,000 variants through the use of two alternative promoters (alpha and beta) and extensive alternative splicing in each family member. Recently, a third promoter (gamma) was identified for this gene in the 3' region. Mutations in this gene are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia. [provided by RefSeq, Aug 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.